Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Tramadol
1993422 citationsDonna McTavish, Eugene M. Sorkin et al.Drugsprofile →
Citations per year, relative to Donna McTavish Donna McTavish (= 1×)
peers
Eugene M. Sorkin
Countries citing papers authored by Donna McTavish
Since
Specialization
Citations
This map shows the geographic impact of Donna McTavish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna McTavish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna McTavish more than expected).
This network shows the impact of papers produced by Donna McTavish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna McTavish. The network helps show where Donna McTavish may publish in the future.
Co-authorship network of co-authors of Donna McTavish
This figure shows the co-authorship network connecting the top 25 collaborators of Donna McTavish.
A scholar is included among the top collaborators of Donna McTavish based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Donna McTavish. Donna McTavish is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
McClellan, Karen J., Lynda R. Wiseman, & Donna McTavish. (1998). Cerivastatin. Drugs. 55(3). 415–420.28 indexed citations
2.
Goa, Karen L., Lee B. Barradell, & Donna McTavish. (1997). Simvastatin. PharmacoEconomics. 11(1). 89–110.14 indexed citations
3.
Noble, Stuart & Donna McTavish. (1995). Levocabastine. Drugs. 50(6). 1032–1049.43 indexed citations
Buckley, Micaela M.-T., Susan Grant, Karen L. Goa, Donna McTavish, & Eugene M. Sorkin. (1990). Diltiazem. Drugs. 39(5). 757–806.139 indexed citations
20.
McTavish, Donna & Eugene M. Sorkin. (1989). Verapamil. Drugs. 38(1). 19–76.217 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.